MG
ROIVW

Michael Gelband’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Michael Gelband’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,563
Closed -$15K – 2437
2022
Q2 		$15K Hold
24,563
– – ﹤0.01% 1859
2022
Q1 		$22K Hold
24,563
– – ﹤0.01% 2102
2021
Q4 		$50K Buy
+24,563
New +$37.5K ﹤0.01% 2032

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
CC
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Michael Gelband's ROIVW Position: Q3 2022 in Review

Michael Gelband sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2022, closing a stake of 24,563 shares — an estimated $15K sold.

Michael Gelband first reported a position in ROIVW in Q4 2021 and held it in 3 quarters. The position peaked at $50K in Q4 2021. 30 funds tracked by Wall St. Rank hold ROIVW as of Q3 2022.

  • Michael Gelband reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2022 after selling out during the quarter.
  • Michael Gelband sold 24,563 Roivant Sciences Ltd. Warrant shares in Q3 2022, an estimated $15K.
  • Michael Gelband first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 3 quarters.
  • Michael Gelband's Roivant Sciences Ltd. Warrant position peaked at $50K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.